Furthermore, a large body of evidence associates the activation of the IFN pathway and tumor development [182], whilst lower levels of IL10 cytokine were detected in the sera of HCV-HCC, suggesting that further studies are required to assess whether IL10 supports anti-tumor immunity [183]. This evidence concerns the gene IL10 and neoplasm.